Arthritis after SARS-CoV-2 infection

Baimukhamedov, Chokan; Barskova, Tatiana; Matucci‐Cerinic, Marco

doi:10.1016/s2665-9913(21)00067-9

Cited by 44 publications

(49 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We also included in our review case reports from Novelli and Baimukhamedov [ 34 , 35 ]. The first described the case of a 27-year-old woman who developed psoriatic spondyloarthritis triggered by SARS-CoV-2 infection.…”

Section: Resultsmentioning

confidence: 99%

“…The patient developed peripheral arthritis and mild bilateral sacroiliitis confirmed on MRI; she was HLA-B27 negative and had a family medical history of psoriasis [ 34 ]. Baimukhamedov et al reported the development of chronic arthritis, which fulfilled the classification criteria for seropositive rheumatoid arthritis, one month after COVID-19 infection [ 35 ].…”

Section: Resultsmentioning

confidence: 99%

“…Regarding articular involvement, some cases of arthritis have been described after SARS-CoV-2 infection, as could happen in other viral diseases, but further studies and long-term follow-up are required [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ].…”

Section: Introductionmentioning

confidence: 99%

“…Sometimes patients can develop other musculoskeletal symptoms and signs, such as enthesitis, tenosynovitis or dactylitis [ 13 , 14 , 15 , 16 , 17 , 18 , 20 , 21 , 22 , 24 , 27 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ]; isolated reactive inflammatory sacroiliac involvement after COVID-19 has been rarely recorded.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature

Colatutto

Sonaglia

Zabotti

et al. 2021

Viruses

View full text Add to dashboard Cite

Severe acute respiratory coronavirus-2 syndrome (SARS-CoV-2) is a well-known pandemic infectious disease caused by an RNA virus belonging to the coronaviridae family. The most important involvement during the acute phase of infection concerns the respiratory tract and may be fatal. However, COVID-19 may become a systemic disease with a wide spectrum of manifestations. Herein, we report the natural history of sacroiliac inflammatory involvement in two females who developed COVID-19 infection with mild flu-like symptoms. After the infection they reported inflammatory back pain, with magnetic resonance imaging (MRI) studies showing typical aspects of sacroiliitis. Symptoms improved with NSAIDs therapy over the following months while MRI remained positive. A literature review was performed on this emerging topic. To our knowledge, this is the first MRI longitudinal study of post-COVID-19 sacroiliitis with almost one year of follow-up. Predisposing factors for the development of articular involvement are unclear but a long-lasting persistence of the virus, demonstrated by nasopharyngeal swab, may enhance the probability of altering the immune system in a favourable background.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature

Colatutto

Sonaglia

Zabotti

et al. 2021

Viruses

View full text Add to dashboard Cite

show abstract

“…Virale Arthritiden manifestieren sich üblicherweise mit einer symmetrischen Polyarthritis kleiner Gelenke, nur sehr selten als Monooligoarthritis und heilen meist spontan ab [15]. So wurden auch nach SARS-CoV-2-Infektionen vereinzelt akute Polyarthritiden beobachtet, v. a. mit positivem Antikörper gegen citrulliniertes Protein (ACPA), aber wohl eher zufällig und nicht in kausalem Zusammenhang [16][17][18][19][20]. Die akute, nach 4 Wochen remittierte Rheumafaktor-positive, ACPA-negative Polyarthritis einer 27-jährigen Frau dürfte eher in die zuvor erwähnten Post-COVID-19-Arthritiden einzuordnen sein, auch wenn sie als ReA klassifiziert wurde [21].…”

Section: Diskussionunclassified

Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis

Zeidler

2021

Z Rheumatol

View full text Add to dashboard Cite

ZusammenfassungEs werden 13 Fallberichte einer reaktiven Arthritis im Zusammenhang mit einer Coronavirus-Krankheit-2019 (COVID‑19) referiert. Männer sind häufiger betroffen als Frauen. Die Arthritis manifestiert sich 4 bis 44 Tage nach der Infektion bzw. dem Auftreten der COVID‑19-Symptome. Die akute Arthritis ist monoartikulär oder oligoartikulär. Nur einer von 7 untersuchten Patienten war Humanes-Leukozyten-Antigen(HLA)-B27-positiv. Eine direkte virale Infektion des Gelenkes mit „severe acute respiratory syndrome coronavirus 2“ (SARS-CoV‑2) wurde in der Synovialflüssigkeit nicht nachgewiesen und in der Synovialis nicht untersucht. Die Arthritis wurde mit nichtsteroidalen Antirheumatika und/oder intraartikulären oder systemischen Kortikosteroiden erfolgreich behandelt. Die Pathogenese der post-COVID‑19-reaktiven Arthritis ist ungeklärt.

show abstract

Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review

Mudge,

Honey,

Tachoukaft

et al. 2023

Arthritis Care & Research

View full text Add to dashboard Cite

Musculoskeletal symptoms are commonly reported following acute coronavirus disease 2019 (COVID‐19). It is unclear whether those with musculoskeletal symptoms subsequently develop inflammatory rheumatic musculoskeletal disease (iRMD). This review seeks to identify evidence for an association between acute COVID‐19 and subsequent iRMD diagnosis. A rapid review of the literature using a systematic search of Medline, EMBASE and two COVID‐19 databases was undertaken until August 2022. Case studies, case series, cross‐sectional, case‐control, and cohort studies reporting patients with an incident iRMD following COVID‐19 were included. Title and abstract screening were conducted by one reviewer, and full text screening by two reviewers. Data extraction and quality appraisal were by one reviewer, with a second verifying. Study‐type specific critical appraisal tools were used. Results were narratively synthesised. 80 studies were included (69 case reports, 10 case series and 1 cross‐sectional study). Commonly reported iRMDs were ‘reactive arthropathies’ (studies=47), ‘inflammatory arthropathies unspecified’ (studies=18), rheumatoid arthritis (studies=12) and lupus erythematosus (studies=11). The cross‐sectional study reported 37% of those with COVID‐19 developed ‘post‐covid arthritis.’ Time from diagnosis of COVID‐19 to iRMD presentation ranged from 0‐120 days. Several mechanisms were proposed to explain the association between COVID‐19 and iRMD development: auto‐immune processes, aberrant inflammatory responses, colonisation of joint spaces, direct damage from the SARS‐CoV2 virus and genetic predisposition. The level of evidence of the studies included in this review was low, and the quality generally poor. Prospective observational studies are required to confirm associations and likely impact of post COVID‐19 iRMDs at a population level.

show abstract

Arthritis after SARS-CoV-2 infection

Cited by 44 publications

References 5 publications

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature

Post-COVID‑19-Arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis

Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review

Contact Info

Product

Resources

About